Seshadri Neervannan
2023
In 2023, Seshadri Neervannan earned a total compensation of $1.7M as Chief Operating Officer at Tarsus Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $246,000 |
|---|---|
| Option Awards | $488,623 |
| Salary | $500,000 |
| Stock Awards | $494,095 |
| Other | $13,200 |
| Total | $1,741,918 |
Neervannan received $500K in salary, accounting for 29% of the total pay in 2023.
Neervannan also received $246K in non-equity incentive plan, $488.6K in option awards, $494.1K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Seshadri Neervannan's compensation ranked 616th out of 2,647 executives tracked by ExecPay. In other words, Neervannan earned more than 76.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 616 out of 2,647 | 77th |
Division Manufacturing | 345 out of 1,447 | 76th |
Major group Chemicals And Allied Products | 239 out of 817 | 71st |
Industry group Drugs | 235 out of 783 | 70th |
Industry Biological Products, Except Diagnostic Substances | 81 out of 204 | 60th |
Source: SEC filing on April 26, 2024.
Neervannan's colleagues
We found three more compensation records of executives who worked with Seshadri Neervannan at Tarsus Pharmaceuticals in 2023.